Revivocell awarded Future Innovation Fund for the development of a novel COVID-19 screening platform
Revivocell is delighted to have been awarded Future Innovation Fund from the Liverpool City Region for the development of a novel screening tool for COVID-19 virus.
With the current COVID-19 pandemic there remains great uncertainty about number of future infections and possible deaths. There is a need for more accurate and cost effective detection tools that can be widely used without highly specialised training and expensive equipment. The current established detection tools are expensive and require dedicated equipment, trained personnel and numerous reagents which are running low.
Revivocell will be collaborating with Daresbury Proteins to develop the new COVID-19 testing platform, which is rapid, easy to use, lower cost and highly accurate.
Mar 12, 2021 • Posted by conzpzctji
Muchas gracias. ?Como puedo iniciar sesion?
Dec 09, 2020 • Posted by Andy Cairns
Congratulations on the FIF. I work for The Innovation Agency and I’m the Commercial Programme Manager and my role is to provide support to Life Science companies in the Liverpool City Region. Happy to catch up and tell you a bit more about our free service.